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Vero cytotoxin-producing Escherichia coli
serogroup O157 (VTEC O157) was first
recognized as a human pathogen in 1982 (1).
Infection results in symptoms ranging from mild
diarrhea to hemorrhagic colitis (abdominal pain,
diarrhea, and blood in the stool). Hemolytic
uremic syndrome (HUS), characterized by
microangiopathic hemolytic anemia, thrombocy-
topenia, and renal failure, develops in 2% to 7%
of cases (2). The number of laboratory isolations
of VTEC O157 from human infections in England
and Wales has risen from 76 in 1986 (3) to 1,087
in 1997 (4). However, the number of laboratories
examining feces for VTEC O157 has increased in
England, as have protocols emphasizing the
importance of laboratory examination. Many
surveillance networks worldwide have selection
criteria for testing for VTEC O157, such as the
presence of blood in the stools and clinical or age
parameters (5). In contrast, population-based
surveillance has been undertaken in Wales since
February 1990, with all first-time acute-phase
fecal specimens tested for VTEC O157 (6). The
objectives of this surveillance are to measure the
incidence of VTEC O157, identify outbreaks of
infection, and describe the persons involved and
the microbiologic characteristics of the isolates.
We report on 9 years of surveillance through the
end of 1998. Since the system is population-
based, the figures differ from those in some
published reports of specimens submitted to the
reference laboratory (4,7,8).
Fecal samples were cultured on Sorbitol
MacConkey agar (Oxoid, Basingstoke, UK) and
incubated at 37°C for 18 hours (3). Sorbitol
nonfermenting colonies were tested for latex
agglutination with O157 antiserum (Oxoid) and
were biochemically confirmed as Escherichia coli
by API 20E (BioMerieux sa69280 Marcy L’Etoile,
France). Laboratories were asked to send all
presumptive VTEC O157 isolates to the
Laboratory of Enteric Pathogens, Central Public
Health Laboratory, London, for confirmation,
phage-typing, and Vero cytotoxin typing (8).
Cases, defined as “isolation of VTEC,
confirmed by standard methods, from a fecal
specimen submitted by a resident of Wales,” were
reported to the Public Health Laboratory Service
Communicable Disease Surveillance Centre
(CDSC) (Wales). Nine cases were excluded
because the E. coli O157 isolate did not express
Vero cytotoxin genes. Epidemiologic and clinical
information was recorded on a standard
structured questionnaire. Household contacts
were screened where practicable and were
included if they met the case definition. HUS,
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Population-based surveillance for Vero cytotoxin-producing Escherichia coli
(VTEC) O157 has been carried out in Wales since 1990. The annual incidence has
remained stable during the 9-year period (mean: 1.6 cases per 100,000 population); the
rate is highest in children younger than 5 years of age. Blood in the stool is reported in
fewer than half the cases, indicating the importance of screening all fecal specimens for
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which in the United Kingdom is defined as renal
impairment including oligouria and plasma
creatinine elevated for age, microangiopathic
hemolytic anemia, and thrombocytopenia, was
diagnosed clinically.
The annual incidence was calculated by
using as the denominator the mid-year
population estimates for Wales (Office of
National Statistics [ONS]), and the age and sex
distribution of patients was calculated by using
the mid-1996 population estimate (ONS). The
Poisson distribution was used to calculate 95%
confidence intervals (CI) for age-specific rates.
To assess seasonality, the frequency of cases by
month of onset was examined. (For asymptom-
atic cases, the date of the sample was used.)
Incidence by health authority areas was
calculated by using post-1996 boundaries. The
proportions of cases with various symptoms were
determined, and 95% CI were calculated by
using standard error of proportions. The
duration of illness (up to the date of interview),
admission to hospital and length of stay, and
proportion with HUS (95% CI) were calculated.
From 1990 through 1998, 415 cases were
reported (mean = 1.6 per 100,000 population per
year), with little change in incidence (1.0 per
100,000 population in 1994 to 2.8 per 100,000
population in 1995, when an outbreak of 49 cases
occurred) (Table 1) (9). Seventy-four cases
(17.8%) were part of six outbreaks involving
Welsh residents (Table 1). Three of the outbreaks
have been reported elsewhere (9-11). The
remaining 341 (82.2%) were sporadic cases, of
which 283 (83.0%) were index cases (the first
reported from each household) (from 72.3% in
1998 to 96.2% in 1993). Fifty-eight (17.0%)
sporadic cases were in household contacts; 26 of
these patients had diarrhea, including five with
blood in the stools.
Of 415 patients, 207 (49.9%) were males,
ages 3 months to 89 years (mean = 25 years,
median = 18 years, mode = 1). The incidence of
VTEC O157 was highest in children younger
than 5 years (8.8 per 100,000 population) (Table
2). The number of cases peaked in August, and
more than half (227) of the cases occurred during
July, August, and September. Only four cases
occurred during December. Cases were reported
from all five health authority areas in Wales. The
highest incidence was in the northern and
western areas (North Wales and Dyfed/Powys)
(mean annual incidences 2.5 and 2.4 per 100,000
population, respectively). The lowest incidences
were reported in the more densely populated
areas of Gwent (1.1 per 100,000), Bro Taf (1.1 per
100,000), and Iechyd Morgannwg (1.0 per
100,000).
Of the 415 patients, 339 (81.7%, CI = 78.3%-
85.7%) had diarrhea, 259 (62.4%, CI = 57.3%-
66.7%) reported abdominal pain, and 192 (46.3%,
CI = 41.3%-50.7%) had blood in the stool; 172
(41.4%, CI = 36.3%-45.7%) had hemorrhagic
colitis. One third of the patients reported
vomiting (32.3%, CI = 27.5%-36.5%) or feeling
feverish (34.0%, CI = 29.5%-38.5%); 62 (14.9%, CI
= 11.5%-18.5%) were asymptomatic. The highest
proportion of asymptomatic cases was in the 25-
to 34-year-old age group (18 [40.1%] of 44) who
are often the caretakers of symptomatic patients;
Table 1. Occurrence and annual incidence of VTEC O157 in Wales, 1990–1998
Total no.
of cases
(rate per No. of No. of
100,000 sporadic cases outbreak Outbreak summary
Year population)    (no. of index cases) cases (setting, mode of spread, phage and verotoxin types)
1990 32 (1.1) 28 (24)   4 Psychogeriatric ward, person to person, PT14,
  VT1&2.
1991 39 (1.3) 30 (28)   9 Day nursery, person to person, PT49, VT2.
1992 41 (1.4) 41 (33)   0 -
1993 34 (1.2) 26 (25)   8 Community, Meat from 1 shop, PT49, VT2.
1994 29 (1.0) 29 (24)   0 -
1995 82 (2.8) 33 (30) 49 Day nursery, person to person, PT2 VT2.
1996 38 (1.3) 38 (31)   0 -
1997 55 (1.9) 51 (41)   3 Home for the elderly mentally infirm, person to
person, PT2, VT2.
  1 Part of a European outbreak
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in 17 cases HUS developed (4.1%, CI = 2.4%-
6.5%), age range: 1 to 50 years (mean = 9 years,
median = 3 years); 10 HUS patients were less
than 1 to 4 years of age, for a complication rate in
this age group of 8.5%.
Diarrheal illness lasted as long as 330 days
(median and mode = 6 days); 118 (28.4%) patients
were admitted to hospital. The length of stay,
first recorded in 1994, was from 1 to 71 days
(mode 1 day, median 4.0 days). The highest rate
of hospitalization was among those >65 years old
(25 [62.5%] of 40). The mean annual proportion of
index cases hospitalized was 36.1% (24.0% in
1993 to 48.5% in 1992). From 1994 through 1998,
only one person, an 88-year-old woman with
diarrhea, died as a result of the infection.
Three hundred seventy-eight (91.1%) iso-
lates were sent to the Laboratory of Enteric
Pathogens for confirmation and typing. Of these,
62 (16.4%, CI = 6.4%-26.4%) had both verotoxin
type (VT) 1 and VT2 genes, and 316 (83.6%, CI =
79.9%-87.3%) had VT2 only. Isolates belonged to
at least 19 phage types (PT). The two most
common PT were PT2 (160 isolates [42.3%]) and
PT49 (48 isolates [12.7%]). Other PT accounting
for 5% (19) or more isolates were PT1, PT4, PT8,
and PT14. PT2 was the most common type in
each year, with the exception of 1993, when PT49
predominated. PT and verotoxin type were
linked: VT2-only strains included 98% (158 of
160) of the PT2 and all the PT49 isolates.
No relationship was found between the
major PTs and clinical symptoms. More cases
with strains producing VT1+2 had hemorrhagic
colitis (39 [63.9%] of 61) than cases with VT2 only
(120 [42.9%] of 280) (relative risk = 1.69, 95% CI
= 1.18-1.88). In contrast, 16 of the 17 isolates
from cases of HUS had the VT2 gene only. These
isolates were predominantly PT2 (n = 10), but
also included PT49 (n = 4), PT21 (n = 1) and
RDNC (n = 1).
Foreign travel in the week before onset of
symptoms was reported by 37 (8.9%) patients (0
in 1990 to 12 in 1998 [18.5%] of cases). The PTs
among those who had traveled abroad differed
from the overall pattern, the most common being
PT8 (10 cases), RDNC (5 cases), and PT21 (4 cases).
Population-based surveillance of VTEC O157
in Wales has been undertaken since 1990 and is
the most complete in the world. There is no
evidence that pathology referrals have changed
during the study period. General practitioners
(primary-care physicians) were given no specific
incentives for submitting specimens. Palmer
et al. (12) showed that in 1996, 26% patients with
suspected food poisoning attending general-
practitioner clinics submitted fecal specimens.
This is similar to the 27% reported during a
study of patients with infectious gastroenteritis
reporting to general practitioners in England
(13). Although VTEC O157 is regarded as an
emerging pathogen, in Wales its incidence has
remained stable through 1998, and VTEC O157
is a rare (1.6 cases per 100,000 population) but
serious disease.
Public health policy concerning VTEC O157
has been driven by the circumstances surround-
ing outbreaks (14). However, in Wales most cases
(82.2%) occur sporadically, and because all first-
time specimens and PTs are examined and
epidemiologic investigations are conducted, it is
unlikely that outbreaks were missed. The
surveillance data, as well as providing a
background against which to measure changes
in incidence, have provided useful information
about VTEC O157 infections. The presence of
blood in the stool is often used in many countries
as a criterion for examining for VTEC O157, yet
fewer than half the Welsh patients reported the
presence of blood, demonstrating the value of
screening all acute-phase fecal specimens.
Although 14.9% of cases were asymptomatic, the
risk for transmission is still present because of
the low infectious dose (11).
Strains of VTEC O157 can be differentiated
rapidly by PT and Vero cytotoxin typing,
although even from apparently sporadic cases a
large number of isolates belonged to a few types,
predominantly PT2/VT2 and PT49/VT2. Deter-
mining the VT produced appears to be a
Table 2. Age and sex distribution of cases of VTEC
O157, Wales, 1990–1998
Age
range Total Male Female
<1   24 (7.9, CI = 4.9-11.9) 13   (8.3) 11   (7.5)
1-4 117 (9.0, CI = 7.4-10.7) 71 (10.7) 46   (7.2)
5-14   56 (1.6, CI = 1.2-2.1) 32   (1.8) 24   (1.4)
15-24   44 (1.4, CI = 1.0-1.8) 19   (1.1) 25   (1.6)
25-34   44 (1.2, CI = 0.8-1.6) 19   (1.0) 25   (1.3)
35-44   30 (0.9, CI = 0.6-1.2) 14   (0.8) 16   (0.9)
45-54   33 (1.0, CI = 0.7-1.3) 11   (0.6) 22   (1.3)
55-64   25 (0.9, CI = 0.6-1.5) 10   (0.7) 15   (1.1)
$65   35 (0.9, CI = 0.5-1.1) 15   (0.9) 20   (0.8)
Total 415 (1.6, CI = 1.4-1.7) 207 (1.6) 208 (1.5)
(mean)
Figures in parentheses are mean annual rates per 100,000
population, followed by 95% confidence intervals (CI) for age-
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microbiologic marker of severity, since hemor-
rhagic colitis was more often associated with
VT1+2 strains, and all the cases complicated by
HUS had VT2-only strains. These strains are
consistently more prevalent than other VT types
in cases of HUS in the United Kingdom (7) and
elsewhere. Demonstration of VT by phenotypic
tests or the presence of VT genes is definitive for
VTEC O157. The presence of the H7 antigen is
closely associated with VT positivity but is of
secondary importance, as a significant minority
of VTEC O157 isolated in England and Wales
(14%-20% in 1992-1994) are nonmotile (8). There
was some annual variation in PTs, although as in
England the predominant phage type was PT2.
As with other surveillance reports, the
highest incidence was in children younger than 5
years of age (8). Although fecal specimens are
more likely to be available for this age group, the
isolation rate is also high (6), and person-to-
person spread is most likely (15). In Wales,
person-to-person spread was the most important
factor in four out of five outbreaks, including
those in the children’s day nurseries, which were
the setting for the two largest outbreaks.
Continued surveillance for VTEC O157 will
provide timely reporting of cases and detection
and containment of outbreaks. Ongoing surveil-
lance over the last 9 years in Wales has provided
valuable information about VTEC O157 infec-
tions and demonstrated the wide range of
associated clinical illness.
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